The global market for Generic Drug CRO (Contract Research Organisation) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

CRO (Contract Research Organization) is a company that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis. A CRO may provide such services as biopharmaceutical development, biological assay development, commercialization, clinical development, clinical trials management, pharmacovigilance, outcomes research, and real world evidence.

Generic drug CRO is a CRO company that provides generic drug development services. In terms of generic drugs, CRO companies mainly provide services such as pharmaceutical research (raw material research, preparation research), clinical BE trials, and registration and marketing.

North American market for Generic Drug CRO (Contract Research Organisation) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Generic Drug CRO (Contract Research Organisation) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Generic Drug CRO (Contract Research Organisation) in Pharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Generic Drug CRO (Contract Research Organisation) include Worldwide Clinical Trials, Eurofins Scientific, Celerion, Alliance Pharma, Accelsiors, Innovind Pharma, Avivia, SUNNOVO, Hangzhou Bio-Sincerity Pharma-Tech, Wanbang Biopharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Generic Drug CRO (Contract Research Organisation), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Generic Drug CRO (Contract Research Organisation).

The Generic Drug CRO (Contract Research Organisation) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Generic Drug CRO (Contract Research Organisation) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Generic Drug CRO (Contract Research Organisation) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Generic Drug CRO (Contract Research Organisation) Market Report

Report Metric	Details
Report Name	Generic Drug CRO (Contract Research Organisation) Market
Segment by Type	Pharmaceutical Research BE Test
Segment by Application	Pharmaceutical Companies MAH Customer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Worldwide Clinical Trials, Eurofins Scientific, Celerion, Alliance Pharma, Accelsiors, Innovind Pharma, Avivia, SUNNOVO, Hangzhou Bio-Sincerity Pharma-Tech, Wanbang Biopharma, Guangzhou Boji Medical & Biotechnological, Xinjiang Bai Hua Cun Pharma Tech, Shandong Bestcomm Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Generic Drug CRO (Contract Research Organisation) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Generic Drug CRO (Contract Research Organisation) Market report?

Ans: The main players in the Generic Drug CRO (Contract Research Organisation) Market are Worldwide Clinical Trials, Eurofins Scientific, Celerion, Alliance Pharma, Accelsiors, Innovind Pharma, Avivia, SUNNOVO, Hangzhou Bio-Sincerity Pharma-Tech, Wanbang Biopharma, Guangzhou Boji Medical & Biotechnological, Xinjiang Bai Hua Cun Pharma Tech, Shandong Bestcomm Pharmaceutical

What are the Application segmentation covered in the Generic Drug CRO (Contract Research Organisation) Market report?

Ans: The Applications covered in the Generic Drug CRO (Contract Research Organisation) Market report are Pharmaceutical Companies, MAH Customer, Others

What are the Type segmentation covered in the Generic Drug CRO (Contract Research Organisation) Market report?

Ans: The Types covered in the Generic Drug CRO (Contract Research Organisation) Market report are Pharmaceutical Research, BE Test

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Generic Drug CRO (Contract Research Organisation) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Pharmaceutical Research

1.2.3 BE Test

1.3 Market by Application

1.3.1 Global Generic Drug CRO (Contract Research Organisation) Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical Companies

1.3.3 MAH Customer

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Generic Drug CRO (Contract Research Organisation) Market Perspective (2020-2031)

2.2 Global Generic Drug CRO (Contract Research Organisation) Growth Trends by Region

2.2.1 Global Generic Drug CRO (Contract Research Organisation) Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Generic Drug CRO (Contract Research Organisation) Historic Market Size by Region (2020-2025)

2.2.3 Generic Drug CRO (Contract Research Organisation) Forecasted Market Size by Region (2026-2031)

2.3 Generic Drug CRO (Contract Research Organisation) Market Dynamics

2.3.1 Generic Drug CRO (Contract Research Organisation) Industry Trends

2.3.2 Generic Drug CRO (Contract Research Organisation) Market Drivers

2.3.3 Generic Drug CRO (Contract Research Organisation) Market Challenges

2.3.4 Generic Drug CRO (Contract Research Organisation) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Generic Drug CRO (Contract Research Organisation) Players by Revenue

3.1.1 Global Top Generic Drug CRO (Contract Research Organisation) Players by Revenue (2020-2025)

3.1.2 Global Generic Drug CRO (Contract Research Organisation) Revenue Market Share by Players (2020-2025)

3.2 Global Generic Drug CRO (Contract Research Organisation) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Generic Drug CRO (Contract Research Organisation) Revenue

3.4 Global Generic Drug CRO (Contract Research Organisation) Market Concentration Ratio

3.4.1 Global Generic Drug CRO (Contract Research Organisation) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Generic Drug CRO (Contract Research Organisation) Revenue in 2024

3.5 Global Key Players of Generic Drug CRO (Contract Research Organisation) Head office and Area Served

3.6 Global Key Players of Generic Drug CRO (Contract Research Organisation), Product and Application

3.7 Global Key Players of Generic Drug CRO (Contract Research Organisation), Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Generic Drug CRO (Contract Research Organisation) Breakdown Data by Type

4.1 Global Generic Drug CRO (Contract Research Organisation) Historic Market Size by Type (2020-2025)

4.2 Global Generic Drug CRO (Contract Research Organisation) Forecasted Market Size by Type (2026-2031)

5 Generic Drug CRO (Contract Research Organisation) Breakdown Data by Application

5.1 Global Generic Drug CRO (Contract Research Organisation) Historic Market Size by Application (2020-2025)

5.2 Global Generic Drug CRO (Contract Research Organisation) Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Generic Drug CRO (Contract Research Organisation) Market Size (2020-2031)

6.2 North America Generic Drug CRO (Contract Research Organisation) Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Generic Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025)

6.4 North America Generic Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Generic Drug CRO (Contract Research Organisation) Market Size (2020-2031)

7.2 Europe Generic Drug CRO (Contract Research Organisation) Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Generic Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025)

7.4 Europe Generic Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Generic Drug CRO (Contract Research Organisation) Market Size (2020-2031)

8.2 Asia-Pacific Generic Drug CRO (Contract Research Organisation) Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Generic Drug CRO (Contract Research Organisation) Market Size by Region (2020-2025)

8.4 Asia-Pacific Generic Drug CRO (Contract Research Organisation) Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Generic Drug CRO (Contract Research Organisation) Market Size (2020-2031)

9.2 Latin America Generic Drug CRO (Contract Research Organisation) Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Generic Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025)

9.4 Latin America Generic Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Generic Drug CRO (Contract Research Organisation) Market Size (2020-2031)

10.2 Middle East & Africa Generic Drug CRO (Contract Research Organisation) Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Generic Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025)

10.4 Middle East & Africa Generic Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Worldwide Clinical Trials

11.1.1 Worldwide Clinical Trials Company Details

11.1.2 Worldwide Clinical Trials Business Overview

11.1.3 Worldwide Clinical Trials Generic Drug CRO (Contract Research Organisation) Introduction

11.1.4 Worldwide Clinical Trials Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)

11.1.5 Worldwide Clinical Trials Recent Development

11.2 Eurofins Scientific

11.2.1 Eurofins Scientific Company Details

11.2.2 Eurofins Scientific Business Overview

11.2.3 Eurofins Scientific Generic Drug CRO (Contract Research Organisation) Introduction

11.2.4 Eurofins Scientific Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)

11.2.5 Eurofins Scientific Recent Development

11.3 Celerion

11.3.1 Celerion Company Details

11.3.2 Celerion Business Overview

11.3.3 Celerion Generic Drug CRO (Contract Research Organisation) Introduction

11.3.4 Celerion Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)

11.3.5 Celerion Recent Development

11.4 Alliance Pharma

11.4.1 Alliance Pharma Company Details

11.4.2 Alliance Pharma Business Overview

11.4.3 Alliance Pharma Generic Drug CRO (Contract Research Organisation) Introduction

11.4.4 Alliance Pharma Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)

11.4.5 Alliance Pharma Recent Development

11.5 Accelsiors

11.5.1 Accelsiors Company Details

11.5.2 Accelsiors Business Overview

11.5.3 Accelsiors Generic Drug CRO (Contract Research Organisation) Introduction

11.5.4 Accelsiors Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)

11.5.5 Accelsiors Recent Development

11.6 Innovind Pharma

11.6.1 Innovind Pharma Company Details

11.6.2 Innovind Pharma Business Overview

11.6.3 Innovind Pharma Generic Drug CRO (Contract Research Organisation) Introduction

11.6.4 Innovind Pharma Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)

11.6.5 Innovind Pharma Recent Development

11.7 Avivia

11.7.1 Avivia Company Details

11.7.2 Avivia Business Overview

11.7.3 Avivia Generic Drug CRO (Contract Research Organisation) Introduction

11.7.4 Avivia Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)

11.7.5 Avivia Recent Development

11.8 SUNNOVO

11.8.1 SUNNOVO Company Details

11.8.2 SUNNOVO Business Overview

11.8.3 SUNNOVO Generic Drug CRO (Contract Research Organisation) Introduction

11.8.4 SUNNOVO Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)

11.8.5 SUNNOVO Recent Development

11.9 Hangzhou Bio-Sincerity Pharma-Tech

11.9.1 Hangzhou Bio-Sincerity Pharma-Tech Company Details

11.9.2 Hangzhou Bio-Sincerity Pharma-Tech Business Overview

11.9.3 Hangzhou Bio-Sincerity Pharma-Tech Generic Drug CRO (Contract Research Organisation) Introduction

11.9.4 Hangzhou Bio-Sincerity Pharma-Tech Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)

11.9.5 Hangzhou Bio-Sincerity Pharma-Tech Recent Development

11.10 Wanbang Biopharma

11.10.1 Wanbang Biopharma Company Details

11.10.2 Wanbang Biopharma Business Overview

11.10.3 Wanbang Biopharma Generic Drug CRO (Contract Research Organisation) Introduction

11.10.4 Wanbang Biopharma Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)

11.10.5 Wanbang Biopharma Recent Development

11.11 Guangzhou Boji Medical & Biotechnological

11.11.1 Guangzhou Boji Medical & Biotechnological Company Details

11.11.2 Guangzhou Boji Medical & Biotechnological Business Overview

11.11.3 Guangzhou Boji Medical & Biotechnological Generic Drug CRO (Contract Research Organisation) Introduction

11.11.4 Guangzhou Boji Medical & Biotechnological Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)

11.11.5 Guangzhou Boji Medical & Biotechnological Recent Development

11.12 Xinjiang Bai Hua Cun Pharma Tech

11.12.1 Xinjiang Bai Hua Cun Pharma Tech Company Details

11.12.2 Xinjiang Bai Hua Cun Pharma Tech Business Overview

11.12.3 Xinjiang Bai Hua Cun Pharma Tech Generic Drug CRO (Contract Research Organisation) Introduction

11.12.4 Xinjiang Bai Hua Cun Pharma Tech Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)

11.12.5 Xinjiang Bai Hua Cun Pharma Tech Recent Development

11.13 Shandong Bestcomm Pharmaceutical

11.13.1 Shandong Bestcomm Pharmaceutical Company Details

11.13.2 Shandong Bestcomm Pharmaceutical Business Overview

11.13.3 Shandong Bestcomm Pharmaceutical Generic Drug CRO (Contract Research Organisation) Introduction

11.13.4 Shandong Bestcomm Pharmaceutical Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)

11.13.5 Shandong Bestcomm Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Worldwide Clinical Trials

Hangzhou Bio-Sincerity Pharma-Tech

Wanbang Biopharma

Accelsiors

Innovind Pharma

Guangzhou Boji Medical & Biotechnological

Xinjiang Bai Hua Cun Pharma Tech

Shandong Bestcomm Pharmaceutical

List of Tables

Table 1. Global Generic Drug CRO (Contract Research Organisation) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Pharmaceutical Research

Table 3. Key Players of BE Test

Table 4. Global Generic Drug CRO (Contract Research Organisation) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Generic Drug CRO (Contract Research Organisation) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Generic Drug CRO (Contract Research Organisation) Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Generic Drug CRO (Contract Research Organisation) Market Share by Region (2020-2025)

Table 8. Global Generic Drug CRO (Contract Research Organisation) Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Generic Drug CRO (Contract Research Organisation) Market Share by Region (2026-2031)

Table 10. Generic Drug CRO (Contract Research Organisation) Market Trends

Table 11. Generic Drug CRO (Contract Research Organisation) Market Drivers

Table 12. Generic Drug CRO (Contract Research Organisation) Market Challenges

Table 13. Generic Drug CRO (Contract Research Organisation) Market Restraints

Table 14. Global Generic Drug CRO (Contract Research Organisation) Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Generic Drug CRO (Contract Research Organisation) Market Share by Players (2020-2025)

Table 16. Global Top Generic Drug CRO (Contract Research Organisation) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Drug CRO (Contract Research Organisation) as of 2024)

Table 17. Ranking of Global Top Generic Drug CRO (Contract Research Organisation) Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Generic Drug CRO (Contract Research Organisation) Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Generic Drug CRO (Contract Research Organisation), Headquarters and Area Served

Table 20. Global Key Players of Generic Drug CRO (Contract Research Organisation), Product and Application

Table 21. Global Key Players of Generic Drug CRO (Contract Research Organisation), Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Generic Drug CRO (Contract Research Organisation) Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Generic Drug CRO (Contract Research Organisation) Revenue Market Share by Type (2020-2025)

Table 25. Global Generic Drug CRO (Contract Research Organisation) Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Generic Drug CRO (Contract Research Organisation) Revenue Market Share by Type (2026-2031)

Table 27. Global Generic Drug CRO (Contract Research Organisation) Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Generic Drug CRO (Contract Research Organisation) Revenue Market Share by Application (2020-2025)

Table 29. Global Generic Drug CRO (Contract Research Organisation) Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Generic Drug CRO (Contract Research Organisation) Revenue Market Share by Application (2026-2031)

Table 31. North America Generic Drug CRO (Contract Research Organisation) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Generic Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Generic Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Generic Drug CRO (Contract Research Organisation) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Generic Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Generic Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Generic Drug CRO (Contract Research Organisation) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Generic Drug CRO (Contract Research Organisation) Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Generic Drug CRO (Contract Research Organisation) Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Generic Drug CRO (Contract Research Organisation) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Generic Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Generic Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Generic Drug CRO (Contract Research Organisation) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Generic Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Generic Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031) & (US$ Million)

Table 46. Worldwide Clinical Trials Company Details

Table 47. Worldwide Clinical Trials Business Overview

Table 48. Worldwide Clinical Trials Generic Drug CRO (Contract Research Organisation) Product

Table 49. Worldwide Clinical Trials Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)

Table 50. Worldwide Clinical Trials Recent Development

Table 51. Eurofins Scientific Company Details

Table 52. Eurofins Scientific Business Overview

Table 53. Eurofins Scientific Generic Drug CRO (Contract Research Organisation) Product

Table 54. Eurofins Scientific Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)

Table 55. Eurofins Scientific Recent Development

Table 56. Celerion Company Details

Table 57. Celerion Business Overview

Table 58. Celerion Generic Drug CRO (Contract Research Organisation) Product

Table 59. Celerion Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)

Table 60. Celerion Recent Development

Table 61. Alliance Pharma Company Details

Table 62. Alliance Pharma Business Overview

Table 63. Alliance Pharma Generic Drug CRO (Contract Research Organisation) Product

Table 64. Alliance Pharma Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)

Table 65. Alliance Pharma Recent Development

Table 66. Accelsiors Company Details

Table 67. Accelsiors Business Overview

Table 68. Accelsiors Generic Drug CRO (Contract Research Organisation) Product

Table 69. Accelsiors Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)

Table 70. Accelsiors Recent Development

Table 71. Innovind Pharma Company Details

Table 72. Innovind Pharma Business Overview

Table 73. Innovind Pharma Generic Drug CRO (Contract Research Organisation) Product

Table 74. Innovind Pharma Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)

Table 75. Innovind Pharma Recent Development

Table 76. Avivia Company Details

Table 77. Avivia Business Overview

Table 78. Avivia Generic Drug CRO (Contract Research Organisation) Product

Table 79. Avivia Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)

Table 80. Avivia Recent Development

Table 81. SUNNOVO Company Details

Table 82. SUNNOVO Business Overview

Table 83. SUNNOVO Generic Drug CRO (Contract Research Organisation) Product

Table 84. SUNNOVO Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)

Table 85. SUNNOVO Recent Development

Table 86. Hangzhou Bio-Sincerity Pharma-Tech Company Details

Table 87. Hangzhou Bio-Sincerity Pharma-Tech Business Overview

Table 88. Hangzhou Bio-Sincerity Pharma-Tech Generic Drug CRO (Contract Research Organisation) Product

Table 89. Hangzhou Bio-Sincerity Pharma-Tech Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)

Table 90. Hangzhou Bio-Sincerity Pharma-Tech Recent Development

Table 91. Wanbang Biopharma Company Details

Table 92. Wanbang Biopharma Business Overview

Table 93. Wanbang Biopharma Generic Drug CRO (Contract Research Organisation) Product

Table 94. Wanbang Biopharma Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)

Table 95. Wanbang Biopharma Recent Development

Table 96. Guangzhou Boji Medical & Biotechnological Company Details

Table 97. Guangzhou Boji Medical & Biotechnological Business Overview

Table 98. Guangzhou Boji Medical & Biotechnological Generic Drug CRO (Contract Research Organisation) Product

Table 99. Guangzhou Boji Medical & Biotechnological Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)

Table 100. Guangzhou Boji Medical & Biotechnological Recent Development

Table 101. Xinjiang Bai Hua Cun Pharma Tech Company Details

Table 102. Xinjiang Bai Hua Cun Pharma Tech Business Overview

Table 103. Xinjiang Bai Hua Cun Pharma Tech Generic Drug CRO (Contract Research Organisation) Product

Table 104. Xinjiang Bai Hua Cun Pharma Tech Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)

Table 105. Xinjiang Bai Hua Cun Pharma Tech Recent Development

Table 106. Shandong Bestcomm Pharmaceutical Company Details

Table 107. Shandong Bestcomm Pharmaceutical Business Overview

Table 108. Shandong Bestcomm Pharmaceutical Generic Drug CRO (Contract Research Organisation) Product

Table 109. Shandong Bestcomm Pharmaceutical Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)

Table 110. Shandong Bestcomm Pharmaceutical Recent Development

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

Table 114. Authors List of This Report

List of Figures

Figure 1. Generic Drug CRO (Contract Research Organisation) Picture

Figure 2. Global Generic Drug CRO (Contract Research Organisation) Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Generic Drug CRO (Contract Research Organisation) Market Share by Type: 2024 VS 2031

Figure 4. Pharmaceutical Research Features

Figure 5. BE Test Features

Figure 6. Global Generic Drug CRO (Contract Research Organisation) Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Generic Drug CRO (Contract Research Organisation) Market Share by Application: 2024 VS 2031

Figure 8. Pharmaceutical Companies Case Studies

Figure 9. MAH Customer Case Studies

Figure 10. Others Case Studies

Figure 11. Generic Drug CRO (Contract Research Organisation) Report Years Considered

Figure 12. Global Generic Drug CRO (Contract Research Organisation) Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Generic Drug CRO (Contract Research Organisation) Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Generic Drug CRO (Contract Research Organisation) Market Share by Region: 2024 VS 2031

Figure 15. Global Generic Drug CRO (Contract Research Organisation) Market Share by Players in 2024

Figure 16. Global Top Generic Drug CRO (Contract Research Organisation) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Drug CRO (Contract Research Organisation) as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Generic Drug CRO (Contract Research Organisation) Revenue in 2024

Figure 18. North America Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Generic Drug CRO (Contract Research Organisation) Market Share by Country (2020-2031)

Figure 20. United States Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Generic Drug CRO (Contract Research Organisation) Market Share by Country (2020-2031)

Figure 24. Germany Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Generic Drug CRO (Contract Research Organisation) Market Share by Region (2020-2031)

Figure 32. China Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Generic Drug CRO (Contract Research Organisation) Market Share by Country (2020-2031)

Figure 40. Mexico Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Generic Drug CRO (Contract Research Organisation) Market Share by Country (2020-2031)

Figure 44. Turkey Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Worldwide Clinical Trials Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)

Figure 48. Eurofins Scientific Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)

Figure 49. Celerion Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)

Figure 50. Alliance Pharma Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)

Figure 51. Accelsiors Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)

Figure 52. Innovind Pharma Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)

Figure 53. Avivia Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)

Figure 54. SUNNOVO Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)

Figure 55. Hangzhou Bio-Sincerity Pharma-Tech Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)

Figure 56. Wanbang Biopharma Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)

Figure 57. Guangzhou Boji Medical & Biotechnological Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)

Figure 58. Xinjiang Bai Hua Cun Pharma Tech Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)

Figure 59. Shandong Bestcomm Pharmaceutical Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions